Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 20:41:59.
doi: 10.11604/pamj.2022.41.59.31383. eCollection 2022.

AKT1 and PIK3CA activating mutations in Moroccan bladder cancer patients´ biopsies and matched urine

Hajar El Ahanidi  1   2 , Meryem El Azzouzi  1   2 , Housna Arrouchi  2 , Chaimae Hafidi Alaoui  1 , Mohammed Tetou  3 , Mounia Bensaid  3 , Mohamed Oukabli  2   3 , Ahmed Ameur  2   3 , Abderrahmane Al Bouzidi  2 , Mohammed El Mzibri  1 , Mohammed Attaleb  1
Affiliations

AKT1 and PIK3CA activating mutations in Moroccan bladder cancer patients´ biopsies and matched urine

Hajar El Ahanidi et al. Pan Afr Med J. .

Abstract

Introduction: in cancer cells, activating mutations in PIK3CA and AKT1 genes, major players of PI3K-AKT-mTOR signalling pathway, are widely reported in many cancers and present attractive targets for the identification of new therapeutics and better cancer management. The present study was planned to evaluate the mutational status of PIK3CA and AKT1 genes in bladder cancer patients and to assess the association between these mutations and patients´ clinico-pathological features.

Methods: in this prospective study, bladder cancer biopsies and matched urine sediments samples were collected form 70 patients. Mutations were assessed by deoxyribonucleic acid (DNA) sequencing and correlation with clinico-pathological data was performed using SPSS software.

Results: AKT1 alterations were poorly detected. Only one patient with pT1 stage and high-grade tumour carried the E17K mutation. In PIK3CA exon 9, 2 point mutations, E545K and Q546E, and a SNP (E547E) were reported, whereas in exon 20, 2 point mutations (L989V and H1047R) and 2 SNPs (I1022I and T1025T) were detected. PIK3CA mutations were mainly observed in early stages and high-grade tumours. Statistical analysis showed no significant association between the studied AKT1 and PIK3CA mutations and patients´ clinico-pathological parameters (p > 0.05). Detection of these mutations in voided urine samples showed a high specificity (100%) for both genes and a moderate sensitivity: 100% for AKT1 and 66.7% for PIK3CA genes.

Conclusion: this study shows clearly that mutations in AKT1 and PIK3CA are rare events and could not be considered as valuable biomarkers for bladder cancer management.

Keywords: AKT1; Bladder cancer; Moroccan patients; PIK3CA; activating mutations.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Wong MCS, Fung FDH, Leung C, Cheung WWL, Goggins WB, Ng CF. The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection. Sci Rep. 2018 Jan 18;8(1):1129. - PMC - PubMed
    1. Brausi M, Olaru V. Management of high-risk non-muscle invasive bladder cancer. Minerva Urol Nefrol. 2012 Dec;64(4):255–60. - PubMed
    1. Benider A, Bendahhou K. Registre des cancers de la région du grand Casablanca 2008-2012 Ed. 2016. 2016.
    1. Tazi MA, Er-Raki A, Benjaafar N. Cancer incidence in Rabat, Morocco: 2006-2008. Ecancermedicalscience. 2013 Aug 8;7:338. - PMC - PubMed
    1. Payandeh M, Sadeghi M, Sadeghi E. Characteristics of patients with transitional cell carcinoma of the urinary Bladder in Kermanshah Province, Iran. Iran J Cancer Prev [Internet] 2015 Dec 23;8(6) Cited 2021 Dec 2. - PMC - PubMed

Substances